Ureaplasma parvum Septic Arthritis, a Clinic Challenge.
Carlos Suárez-CuervoConcepción NicolásJonathan Fernández-SuárezAna MorillaJavier FernándezLuis Caminal-MonteroPublished in: Diagnostics (Basel, Switzerland) (2022)
Ureaplasma parvum is usually part of the normal genital microbiota. Rarely, it can cause invasive infections such as septic arthritis or meningitis. A case of a 74-year-old woman with follicular lymphoma who developed cellulitis followed by elbow arthritis with negative routine bacterial cultures is described. U. parvum was identified in the synovial fluid using a broad-range 16S ribosomal RNA gene polymerase chain reaction (PCR) and also in vaginal fluid by a targeted PCR (Anyplex™ II STI-7). Multilocus Sequence Typing (MLST) revealed that isolates from both sources belonged to ST4, a worldwide distributed clone. Treatment consisted of surgery and targeted antibiotic therapy with doxycycline and azithromycin. Evolution showed initial clinical improvement in arthritis despite functional sequelae. Ureaplasma arthritis should be considered as a rare cause of arthritis in negative culture, especially in immunosuppressed patients. In these cases, the treatment is not well established, but according to this and previous works, patients could improve with doxycycline, azithromycin or fluoroquinolone therapy on a prolonged basis.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- newly diagnosed
- ejection fraction
- prognostic factors
- acute kidney injury
- peritoneal dialysis
- primary care
- drinking water
- coronary artery disease
- mesenchymal stem cells
- bone marrow
- coronary artery bypass
- patient reported outcomes
- replacement therapy
- percutaneous coronary intervention
- combination therapy
- smoking cessation